ChurnZero, the platform and partner for customer success, has released the full agenda for ZERO-IN 2024, the essential annual conference for CS leaders. Held in Washington, D.C. from October 16-17...

Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, President and Chief Executive Officer, and Tram Bui, VP of Investor Relations and Corporate...

MSA Safety Incorporated (NYSE: MSA), a global leader in the development of advanced safety products and solutions that protect people and facility infrastructures, announced its participation in...

RTX (NYSE: RTX) President and CEO Chris Calio will speak at the Morgan Stanley 12th Annual Laguna Conference on Wednesday, Sept. 11 at 11:45 a.m. Eastern Time. The presentation will be broadcast...

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today...

The Shyft Group, Inc. (NASDAQ: SHYF) ("Shyft" or the "Company"), the North American leader in specialty vehicle manufacturing, assembly, and upfit for the commercial, retail, and service specialty...

Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in...

Sylvox, the world's first full-scenario TV brand, is set to make waves at this year's IFA exhibition in Berlin and revolutionize how consumers experience entertainment across various scenarios....

Solventum (NYSE: SOLV) executives plan to participate in the following investor conferences: 2024 Wells Fargo Healthcare Conference in Everett, MA on Wednesday, September 4, 2024 at 11:00 a.m. ET....

Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Morgan Stanley 22nd Annual Global Healthcare Conference, September 4-5, 2024. Jeff Simmons, President and CEO, and Todd Young,...